Study Details

Back
Study ID 8232-CL-0002
Study Title A phase 1 study to evaluate the effect of renal impairment on the pharmacokinetics, pharmacodynamics and safety of ASP8232 (part 1) and a multiple dose, placebo-controlled exploratory safety, pharmacokinetic and pharmacodynamic study in type 2 diabetes mellitus subjects with chronic kidney disease (part 2)
Clinicaltrials.gov Identifier NCT02218099
Compound Name ASP8232
Medical Indication or Disease Diabetic kidney disease
Study Sponsor Astellas Pharma Europe BV
Collaborator Not Applicable
Study Start Date 16-Sep-2013
Study Completion Date 09-Sep-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS